New Research Strategy For The Uk Aims To Transform Diabetes Care
Diabetes UK and the National Institute for Health and Care Research (NIHR) have launched a new strategy to set the direction of clinical and applied diabetes research in the UK. Its aim is to improve care and speed up progress towards new treatments for people with or at risk of diabetes.
Research has revolutionised diabetes care. Nowadays, people with diabetes have access to a range of medications, technologies and support to help them with the taxing day-to-day management of their condition and to avoid long-term complications.
But still each week hundreds of people with diabetes die prematurely and thousands are diagnosed with life-changing complications that could have been prevented. Increased investment into diabetes research is needed to help people with or at risk of diabetes live better and longer lives.
To stimulate additional investment into research areas with the greatest need, Diabetes UK and the NIHR have launched the UK Strategy for Clinical and Applied Diabetes Research.
Roadmap for researchers
The strategy sets our six key research areas where increased activity would help to address unmet need. These areas were identified by gathering information on diabetes research funding in the UK during 2014-2019.
Groups of researchers, healthcare professionals and people with diabetes analysed the findings and made recommendations about where there are opportunities to accelerate clinical and applied research to benefit people with or at risk of diabetes sooner.
Their recommendations were then mapped against the research priorities gathered through James Lind Alliance Priority Setting partnerships and the work of the Diabetes Research Steering Groups to make sure that they reflected the views of people with or at risk of diabetes. Read More…